Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05031741 · ClinicalTrials.gov registry record · NA
Reducing Adolescent Sexual and Mental Health Disparities by Increasing Access to Telemedicine and Mobile Care
A NA study of Health Care Utilization, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- NA
- Development phase
- 98
- Enrollment target
- 1
- Study location
NCT05031741: Completed NA study of Health Care Utilization, sponsored by Children's Mercy Hospital Kansas City.
NCT05031741 is a NA study of Health Care Utilization that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 98 participants, below the 917-participant average among 25 other Health Care Utilization trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05031741, a NA study of Health Care Utilization, has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- NA
- Development phase
- 98 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigators will attend a series of community outreach events that provide/demonstrate telemedicine and the Children's Mercy Mobile Unit which is equipped to provide direct patient care. Investigators will engage up to 12 teen peer leaders to encourage healthcare-seeking behaviors and mobilize their social networks to attend outreach events. At all events, the mobile unit will be available for teens to (a) demonstrate the mobile unit and telehealth experience; (b) learn about Sexual and Reproductive Health/Mental Health (SRH/MH) and local care resources; (c) register for future telemedicine care; (d) acquire free over-the-counter emergency contraception, condoms, and pregnancy tests.
Primary Outcome
Look at the uptake frequency in Sexual and Mental health care among participants within 30 days of baseline and educational interventions.
Conditions Studied
Interventions
- OTHER Peer Leader Model
Study Locations (1)
Missouri
- Children's Mercy - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2021-08-05 |
| Est. Completion | 2021-12-28 |
| Phase | NA |
What the finished NCT05031741 record still lists
NCT05031741 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 98 participants, a relatively small participant target, below the 917-participant average among 25 other Health Care Utilization trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Health Care Utilization appearing as the primary indexed condition, and to 1 intervention - of which Peer Leader Model is the first listed.
NCT05031741 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT05031741 about?
NCT05031741 is a clinical study titled "Reducing Adolescent Sexual and Mental Health Disparities by Increasing Access to Telemedicine and Mobile Care". Investigators will attend a series of community outreach events that provide/demonstrate telemedicine and the Children's Mercy Mobile Unit which is equipped to provide direct patient care. Investigators will engage up to 12 teen peer leaders to encourage healthcare-seeking behaviors and mobilize the...
What is the current status of trial NCT05031741?
This trial is currently completed. It is a NA study. The enrollment target is 98 participants. The study started on 2021-08-05. Estimated completion is 2021-12-28.
What conditions does trial NCT05031741 study?
This clinical trial studies the following conditions: Health Care Utilization.
What interventions are being tested in trial NCT05031741?
The interventions under investigation include: Peer Leader Model (OTHER).
Who is sponsoring clinical trial NCT05031741?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05031741 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Health Care Utilization
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05031741's enrollment target sits among peer trials
98 20th of 25 higher than 6 of 25 other Health Care Utilization trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Health Care Utilization trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
UCSD RELINK: Connecting Adults To Supportive Services
RECRUITING · NA
-
ACP Video Intervention for Patients With Life-Limiting Illness
RECRUITING · NA
-
Evaluation of a Health System Integrated Model for Postpartum Education and Support in Rural Populations
RECRUITING · NA
-
Fresh RX: NHS 2020
RECRUITING · NA
-
Universal Basic Income and Structural Racism in the US South: HIV Care
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02926729 · 98 participants · NA
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
- NCT03382977 · 98 participants · Phase 1
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- NCT04577014 · 98 participants · Phase 1
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- NCT04817618 · 98 participants · Phase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI